Raia Drogasil (OTCMKTS:RADLY – Get Free Report) is projected to release its results before the market opens on Tuesday, March 3rd. Analysts expect Raia Drogasil to post earnings of $0.0388 per share and revenue of $2.2769 billion for the quarter.
Raia Drogasil Price Performance
Shares of RADLY stock opened at $5.00 on Friday. The stock has a 50 day moving average price of $4.74 and a 200 day moving average price of $4.12. Raia Drogasil has a 52-week low of $2.17 and a 52-week high of $5.34.
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Further Reading
- Five stocks we like better than Raia Drogasil
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
